MedTrace Logo

Antenatal Corticosteroid in Elective Cesarean Section

NCT03396107 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 498

Last updated 2021-06-21

No results posted yet for this study

Summary

Caesarean section is a risk factor for the development of neonatal respiratory complications, mostly respiratory distress syndrome (RDS) and transient tachypnoea of the new-born, both in term and preterm infants.

Conditions

  • Cesarean Section Complications

Interventions

DRUG

Dexamethasone

Dexamethasone 6mg, IM, 48 hours before cesarean section

DRUG

Placebo

Placebo 6mg, IM, 48 hours before cesarean section

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Ahmed Fayek, Professor · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-17
Primary Completion
2019-11-25
Completion
2020-05-24

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03396107 on ClinicalTrials.gov